GALECTIN THERAPEUTICS INC — Director's Dealing 2013

Nov 19, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2013-11-18

Reporting Person: FREEMAN KEVIN D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-11-18	Common Stock	P	1000	$6.0776	Acquired	2917	Direct

Footnotes

F1: Reflects weighted average price. Range of prices were between $6.040 and $6.115. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.